SE8406197D0 - Proteolytiskt sarforband - Google Patents

Proteolytiskt sarforband

Info

Publication number
SE8406197D0
SE8406197D0 SE8406197A SE8406197A SE8406197D0 SE 8406197 D0 SE8406197 D0 SE 8406197D0 SE 8406197 A SE8406197 A SE 8406197A SE 8406197 A SE8406197 A SE 8406197A SE 8406197 D0 SE8406197 D0 SE 8406197D0
Authority
SE
Sweden
Prior art keywords
necrotic
wound
wounds
powder
cleaning
Prior art date
Application number
SE8406197A
Other languages
English (en)
Other versions
SE8406197L (sv
Inventor
J Turkova
J Stabberg
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS918083A external-priority patent/CS245160B1/cs
Priority claimed from CS918183A external-priority patent/CS245378B1/cs
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of SE8406197D0 publication Critical patent/SE8406197D0/sv
Publication of SE8406197L publication Critical patent/SE8406197L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8406197A 1983-12-08 1984-12-06 Proteolytiskt sarforband SE8406197L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS918083A CS245160B1 (cs) 1983-12-08 1983-12-08 Proteolytický kryt na rány
CS918183A CS245378B1 (cs) 1983-12-08 1983-12-08 Proteolytický kryt na rány

Publications (2)

Publication Number Publication Date
SE8406197D0 true SE8406197D0 (sv) 1984-12-06
SE8406197L SE8406197L (sv) 1985-06-09

Family

ID=25746634

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8406197A SE8406197L (sv) 1983-12-08 1984-12-06 Proteolytiskt sarforband

Country Status (6)

Country Link
US (1) US4613502A (sv)
CA (1) CA1237983A (sv)
DE (1) DE3444746A1 (sv)
FR (1) FR2556222B1 (sv)
GB (1) GB2150833B (sv)
SE (1) SE8406197L (sv)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
FR2600897A1 (fr) * 1986-07-04 1988-01-08 Pf Medicament Pansement proteolytique et absorbant et procede pour sa preparation
HU209955B (en) * 1987-07-01 1994-12-28 Genentech Inc Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities
JPH02219571A (ja) * 1989-02-20 1990-09-03 Kanebo Ltd 修飾プロテアーゼ及びその製造法
US5693625A (en) * 1989-03-09 1997-12-02 Therapeutiques Substitutives Method of regenerating cells and tissues using functionalized dextrans
CZ277766B6 (en) * 1990-01-04 1993-04-14 Vnii Textilno Biologically active material and process for preparing thereof
DE4026153A1 (de) * 1990-08-17 1992-02-20 Sebapharma Gmbh & Co Wundverband
US5133968A (en) * 1990-08-20 1992-07-28 Kanebo, Ltd. Modified protease, method of producing the same and cosmetic products containing the modified protease
NL9001980A (nl) * 1990-09-07 1992-04-01 Pharmalett Int Bv Toepassing van polysacchariden in preparaten voor wondbehandeling.
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
WO1993020838A1 (en) * 1992-04-20 1993-10-28 Rufeld, Inc. Method and compositions for treatment of pyonecrotic processes
GB9322640D0 (en) 1993-11-03 1993-12-22 Platipus Anchors Ltd Improvements in ground anchors
US5387517A (en) * 1994-03-23 1995-02-07 Ethicon, Inc. Thiol activated protease from stem bromelain for treating devitalized tissue
DE19503338C2 (de) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Arzneiform zur Abgabe von Kollagenase an Wunden und Verfahren zu ihrer Herstellung und ihre Verwendung
US5597811A (en) * 1995-04-10 1997-01-28 Amerchol Corporation Oxirane carboxylic acid derivatives of polyglucosamines
US5834008A (en) 1996-09-19 1998-11-10 U.S. Biomaterials Corp. Composition and method for acceleration of wound and burn healing
US6756060B1 (en) 1996-09-19 2004-06-29 Usbiomaterials Corp. Anti-inflammatory and antimicrobial uses for bioactive glass compositions
US6423343B1 (en) 1998-01-23 2002-07-23 Usbiomaterials Corporation Bioactive glass treatment of inflammation in skin conditions
DE19813663A1 (de) * 1998-03-27 1999-10-07 Beiersdorf Ag Wundauflagen zur Entfernung von Störfaktoren aus Wundflüssigkeit
KR100298846B1 (ko) * 1998-09-24 2003-10-22 한국원자력연구소 중화키토산스폰지또는중화키토산/콜라겐혼합스폰지를이용한인공진피
US6060461A (en) * 1999-02-08 2000-05-09 Drake; James Franklin Topically applied clotting material
US6663878B1 (en) 1999-04-29 2003-12-16 Usbiomaterials Corp. Anti-inflammatory bioactive glass particulates
DE60022197T2 (de) 1999-06-14 2006-03-23 Imperial College Innovations Silberhaltige bioglas-zusammensetzungen, die von sol-gel zuständen abgeleitet werden
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
DE10106541B4 (de) * 2001-02-13 2005-05-12 Schill + Seilacher Aktiengesellschaft Enzympräparat und dessen Verwendung in der Gerberei
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
US7407668B2 (en) * 2002-01-24 2008-08-05 Boston Scimed, Inc. Medical articles having enzymatic surfaces for localized therapy
FR2848847B1 (fr) * 2002-12-18 2005-10-14 Coletica Composition cosmetique ou dermopharmaceutique comprenant une enzyme insoluble en milieu aqueux, ainsi que ses utilisations
US20050281806A1 (en) * 2004-06-16 2005-12-22 Collegium Pharmaceutical, Inc., Delaware Compositions for topical enzymatic debridement
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
WO2011042971A1 (ja) * 2009-10-07 2011-04-14 株式会社耐熱性酵素研究所 キチン又はキトサンを含む分解性複合材料
JP2012107033A (ja) * 2012-02-02 2012-06-07 Medafor Inc 局所適用される凝血材料
US9155671B2 (en) 2012-10-16 2015-10-13 Surmodics, Inc. Wound packing device and methods
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
RU2630668C1 (ru) * 2016-07-25 2017-09-11 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Субстанция протеолитического фермента на основе Протосубтилина ГЗХ, иммобилизованного на хитозане, и композиция для лечения гнойно-некротических ран
CN109331219A (zh) * 2018-11-30 2019-02-15 广州润虹医药科技股份有限公司 一种壳聚糖液体敷料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2908614A (en) * 1954-08-10 1959-10-13 Glaxo Lab Ltd Use of dextran in freeze-drying process
GB792544A (en) * 1956-05-07 1958-03-26 American Home Prod Therapeutic composition
US3003917A (en) * 1959-01-14 1961-10-10 Nat Drug Co Wound healing composition
US2997423A (en) * 1959-04-20 1961-08-22 Ohio Commw Eng Co Method of making a composition of sodium carboxymethyl dextran and an antibiotic
US3914413A (en) * 1971-02-10 1975-10-21 Leslie L Balassa Process for facilitating wound healing with N-acetylated partially depolymerized chitin materials
SE452109B (sv) * 1973-01-29 1987-11-16 Pharmacia Ab Rengoringsmedel for vetskande utvertes sarytor
US3940478A (en) * 1974-04-29 1976-02-24 Sutures, Inc. Proteolytic enzymes as adjuncts to antibiotic prophylaxis of contaminated wounds
GB1603640A (en) * 1977-07-20 1981-11-25 Gist Brocades Nv Enzyme particles
US4361551A (en) * 1979-11-05 1982-11-30 Riker Laboratories, Inc. Method of enzymatic debridement
FR2488797A1 (fr) * 1980-08-19 1982-02-26 Lhd Lab Hygiene Dietetique Composition dermatologique, son procede de preparation et son application dans le domaine des pansements

Also Published As

Publication number Publication date
SE8406197L (sv) 1985-06-09
GB8430763D0 (en) 1985-01-16
GB2150833A (en) 1985-07-10
FR2556222A1 (fr) 1985-06-14
GB2150833B (en) 1987-04-15
CA1237983A (en) 1988-06-14
DE3444746A1 (de) 1985-06-20
US4613502A (en) 1986-09-23
FR2556222B1 (fr) 1987-11-20

Similar Documents

Publication Publication Date Title
SE8406197L (sv) Proteolytiskt sarforband
US4904469A (en) Therapeutic agents for enzymatic wound cleaning
US7775998B2 (en) Multi-component dressing for treating wounds of the human or animal body using a reduced pressure
AU569031B2 (en) Dressing granules and their use in treating wounds
BR112015016388B1 (pt) Curativo
DK166066C (da) Bakterieadsorberende praeparat i vanduoploeselig form
JPS555699A (en) External wound treatment material
ATE163861T1 (de) Benutzung von protease nexin-i zur wundheilung
GB2147206A (en) Proteolytic enzyme treatment of wounds
JP2017140231A (ja) 止血材およびそれを含有する創傷被覆材
GB2399289B (en) Hydrocolloid materials for use in wound healing
JPH10151184A (ja) 機能性創傷被覆材
CS245160B1 (cs) Proteolytický kryt na rány
CN2402308Y (zh) 一种活性碳纤维敷料
Abualrub et al. Treatment Effectiveness Analysis Of Patients With Long-Term Healing Wounds By Using Innovative Wound Coatings (Literature Review)
RU93048532A (ru) Способ получения перевязочных материалов
ŠTAMBERG et al. SPHERICAL CELLULOSE WITH CONTROLLED POROSITY FOR BIOMEDICAL INTERACTIONS
De la Cadena et al. RECOMBINANT ALPHA-1-ANTITRYPSIN PITTSBURGH ATTENUATES EXPERIMENTAL GRAM-NEGATIVE SEPTICEMIA

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8406197-7

Effective date: 19881028